Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

ABBOTT LABORATORIES

(ABT)
  Report
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
11/20/2020 11/23/2020 11/24/2020 11/25/2020 11/27/2020 Date
110.89(c) 109.27(c) 107.61(c) 106.41(c) 107.62(c) Last
4 075 245 4 106 070 7 317 237 6 224 141 1 976 543 Volume
-0.10% -1.46% -1.52% -1.12% +1.14% Change
More quotes
Financials (USD)
Sales 2020 33 873 M - -
Net income 2020 4 415 M - -
Net Debt 2020 11 794 M - -
P/E ratio 2020 43,9x
Yield 2020 1,34%
Sales 2021 38 370 M - -
Net income 2021 5 807 M - -
Net Debt 2021 8 924 M - -
P/E ratio 2021 34,2x
Yield 2021 1,45%
Capitalization 191 B 191 B -
EV / Sales 2020 5,98x
EV / Sales 2021 5,20x
Nbr of Employees 107 000
Free-Float 88,9%
More Financials
Company
Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Company focuses on cardiovascular, diabetes care, diagnostics, neuromodulation, nutrition and medicine. It offers products,... 
More about the company
All news about ABBOTT LABORATORIES
11/21ABBOTT LABORATORIES : Change in Directors or Principal Officers (form 8-K)
AQ
11/19ABBOTT LABORATORIES : Becomes first anchor sponsor of american diabetes associat..
AQ
11/18ABBOTT LABORATORIES : Launches the first infant formula in canada with an ingred..
AQ
11/17ABBOTT LABORATORIES : Launches the First Infant Formula in Canada with an Ingred..
AQ
11/17ABBOTT LABORATORIES : Named industry sustainability leader for the eighth year i..
AQ
11/16HHS Official Says The Agency Has Responded To Every State That Has Requested ..
RE
11/16ABBOTT : Named Industry Sustainability Leader for the Eighth Year in a Row on th..
PR
11/13ABBOTT LABORATORIES : Entry into a Material Definitive Agreement, Termination of..
AQ
11/12ABBVIE : Vice Chairman, Chief Commercial Officer Carlos Alban to Retire
DJ
11/11ABBOTT LABORATORIES : Announces the u.s. launch of the ionicrf generator for use..
AQ
11/10ABBOTT : Announces the U.S. Launch of the IonicRF™ Generator for Use in Pa..
PR
11/07Many Nursing Homes Shun Free Covid-19 Testing Equipment
DJ
11/05ABBOTT LABORATORIES : Management's Discussion and Analysis of Financial Conditio..
AQ
11/02ABBOTT LABORATORIES : Wins prestigious prix galien usa award for first-of-its-ki..
AQ
10/30ABBOTT : Wins Prestigious Prix Galien USA Award for First-of-its-Kind MitraClip&..
PR
More news
News in other languages on ABBOTT LABORATORIES
11/24CORONAVIRUS : Mepha distribue en Suisse le test rapide d'Abbott
11/24Generikafirma Mepha holt weiteren Covid-19-Schnelltest in die Schweiz
10/26AVIS D'ANALYSTES DU JOUR : Adidas, Chargeurs, Daimler, EDF, Ipsen, L'Oréal, SAP,..
10/26Seconde vague
10/23Les résultats et les couvre-feux se ramassent à la pelle
More news
Analyst Recommendations on ABBOTT LABORATORIES
More recommendations
Chart ABBOTT LABORATORIES
Duration : Period :
Abbott Laboratories Technical Analysis Chart | ABT | US0028241000 | MarketScreener
Technical analysis trends ABBOTT LABORATORIES
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 118,44 $
Last Close Price 107,62 $
Spread / Highest target 20,8%
Spread / Average Target 10,1%
Spread / Lowest Target -23,8%
EPS Revisions
Managers
NameTitle
Robert B. Ford President, CEO, Chief Operating Officer & Director
Miles D. White Executive Chairman
Robert E. Funck Chief Financial Officer & Executive Vice President
Roxanne Schuh Austin Independent Director
Samuel C. Scott Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ABBOTT LABORATORIES23.90%190 742
ALIGN TECHNOLOGY, INC.70.41%37 493
SARTORIUS STEDIM BIOTECH98.78%32 358
SYSMEX CORPORATION40.76%21 519
AMERISOURCEBERGEN CORPORATION21.28%21 079
BIO-RAD LABORATORIES, INC.44.60%15 912